Actively Recruiting
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Subsyndromal Mental Ill-health ( PRIMARITA-2 )
Led by Karolinska Institutet · Updated on 2025-03-07
500
Participants Needed
1
Research Sites
206 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
R
Region Stockholm
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to investigate if online transdiagnostic cognitive behavior therapy (CBT) can be effective in the treatment of subsyndromal mental ill-health in adult primary care patients. The main aim is to investigate: if online transdiagnostic CBT yields superior symptomatic improvement compared to care-as-usual when given in a primary care context to patients with mental ill-health. Researchers will compare online transdiagnostic CBT to primary care as usual to see if psychiatric symptoms can be reduced. Participants will be randomized to online transdiagnostic CBT or primary care as usual. Participants in online transdiagnostic CBT will receive a cognitive behavioral treatment provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. Participants randomized to care as usual will receive health care services as usual in primary care. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project, but the investigators expect that participants will receive an active treatment.
CONDITIONS
Official Title
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Subsyndromal Mental Ill-health ( PRIMARITA-2 )
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a subsyndromal mental health problem involving anxiety, depressive symptoms, or stress-related ill-health that requires treatment
- Be at least 18 years old
- Have regular access to a device with an Internet connection
- Be able to read and write in Swedish
- Have no severe psychiatric disorder requiring specialized psychiatric care such as psychosis, bipolar disorder, or anorexia nervosa
- If on monoamine agonist medication, have had a stable dosage for the past month
- Have no ongoing psychological treatment
- Provide written informed consent and complete baseline assessment
You will not qualify if you...
- Meet diagnostic criteria for anxiety disorders including social phobia, panic disorder, agoraphobia, general anxiety disorder, or specific phobia
- Have a health anxiety disorder such as hypochondriasis or illness anxiety disorder
- Have obsessive-compulsive disorder
- Have depression or dysthymia
- Have stress-related disorders such as exhaustion disorder, adjustment disorder, or post-traumatic stress disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Region Stockholm, Gustavsberg Primary Care Center
Gustavsberg, Stockholm County, Sweden, 134 40
Actively Recruiting
Research Team
M
Mari von Bahr Bentzer, MSc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here